issues in oncology
survivorship
cost of care

AACR’s Cancer Progress Report Details Major Advances in Cancer and Rising Costs of Treatment

The American Association for Cancer Research (AACR) 2015 Cancer Progress Report highlighted the accelerated pace of the number of U.S. Food and Drug Administration (FDA)-approved targeted therapies over the past 5 years, which reached 52 this year; the dramatic increase in the 5-year survival rate...

supportive care
cost of care

Earlier Palliative Care Consultation Associated With Cost Savings

In a prospective cohort study reported in the Journal of Clinical Oncology, May et al found that earlier palliative care consultation for inpatients with advanced cancer was associated with lower total direct costs. Study Details The study included 969 patients with advanced cancer admitted to 5...

health-care policy
hematologic malignancies
leukemia
issues in oncology
issues in oncology
cost of care

Study Finds Current Prices of Hematologic Cancer Drugs Are Not Justified

The costs associated with cancer drug prices have risen dramatically over the past 15 years, a trend concerning to many oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded that the majority of existing treatments for hematologic cancers are...

issues in oncology
issues in oncology
cost of care

ASCO Publishes Conceptual Framework to Assess the Value of New Cancer Treatment Options

In a press conference today, ASCO detailed the contents of the initial version of a conceptual framework for assessing the value of new cancer treatment options based on the treatment’s clinical benefit, side effects, and cost. Other important measures, such as quality of life and...

palliative care
issues in oncology
prostate cancer
issues in oncology
cost of care

Chemotherapy May Be Preferred Option for Some With Advanced Prostate Cancer

In a small clinical trial, scientists at Johns Hopkins Kimmel Cancer Center and James Buchanan Brady Urological Institute found that men with advanced prostate cancer and detection of androgen receptor splice variant-7 (AR-V7) respond to chemotherapy just as well as men who lack the variant. The...

breast cancer
colorectal cancer
health-care policy
issues in oncology
issues in oncology
issues in oncology
cost of care

Colorectal Cancer Screening Increase May Reflect Affordable Care Act Provision

Screening for colorectal cancer increased in individuals with a lower socioeconomic status after 2008, perhaps reflecting the Affordable Care Act’s removal of financial barriers to screening, according to a new analysis. The study, by American Cancer Society investigators, was published by...

prostate cancer
issues in oncology
issues in oncology
issues in oncology
cost of care

Study Examines Impact of Hospital Volume on Complication Rates in Patients Undergoing Robotic Prostate Surgery

A disincentive for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a study published by Sammon et al in BJU International. The study compared complication rates in hospitals with low...

health-care policy
issues in oncology
issues in oncology
cost of care

Study Finds Price of Cancer Drugs Varies Widely Based on Who’s Paying

Uninsured cancer patients are paying anywhere from 2 to 43 times what Medicare would pay for chemotherapy drugs, according to a new study from the University of North Carolina at Chapel Hill. These findings were published by Dusetzina et al in Health Affairs. Major Discrepancies Researchers led...

gynecologic cancer
head and neck cancer
issues in oncology
cost of care

Increasing Number of Boys Vaccinated Against HPV Could Protect More People at the Same Price

Public health programs that devote a portion of their funding to encourage more boys to be vaccinated against human papillomavirus (HPV)—rather than merely attempting to raise coverage among girls—may ultimately protect more people for the same price, a study from Duke University...

cost of care

Study Finds Oncology Drug Pricing Models ‘Not Rational’

A statistical analysis of 51 oncology drugs approved by the U.S. Food and Drug Administration (FDA) between January 1, 2009, and December 31, 2013, has found that cancer drug prices are rising faster than the prices in other sectors of health care and that the high cost of the drugs is not...

issues in oncology
issues in oncology
issues in oncology
cost of care

Experts Explore the Reasons Behind the High Cost of Cancer Drugs in America

Increasingly high prices for cancer drugs are affecting patient care, as well as the health-care system overall, in the United States. These findings were published in a special article by Rajkumar and Kantarjian in the journal Mayo Clinic Proceedings. “Americans with cancer pay 50% to 100%...

issues in oncology
issues in oncology
issues in oncology
cost of care

Study Finds U.S. Spends More on Cancer Care but Saves Fewer Lives Than Western Europe

Despite sharp increases in spending on cancer treatment, cancer mortality rates in the United States have decreased only modestly since 1970. Researchers led by Samir Soneji, PhD, of Dartmouth's Norris Cotton Cancer Center and The Dartmouth Institute for Health Policy & Clinical Practice...

colorectal cancer
cost of care

Cost-Effectiveness Analysis of First- and Second-Line Bevacizumab Plus Chemotherapy in Metastatic Colorectal Cancer

In a U.S.-based cost-effectiveness analysis reported in the Journal of Clinical Oncology, Goldstein et al found high costs per quality-adjusted life-year with the addition of bevacizumab (Avastin) to chemotherapy in first- and second-line treatment of metastatic colorectal cancer. Study Details...

lung cancer
issues in oncology
issues in oncology
cost of care

Genetic Screening Deemed Cost-Effective in
Non–Small Cell Lung Cancer

Multiplexed genetic screening for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene rearrangements, and subsequent biomarker-guided treatment, is cost-effective compared with standard chemotherapy treatment without any molecular testing in the metastatic...

cost of care

Many Insured Patients Alter Their Lifestyles and Medical Care to Cope With Cancer Treatment Costs

A small nationwide survey finds many insured patients are changing their lifestyle and medical care in the face of treatment-related financial burdens. In fact, more than one-third adopted medical care–altering strategies, with younger and lower-income patients being more likely to alter...

Advertisement

Advertisement

;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.